IMAMURA Masaru

イマムラマサル | IMAMURA Masaru

Affiliation and department：
Research theme for competitive and other funds (6)：

2022 - 2025 メモリー様分化誘導を基盤とした多種類のがんに有効なCAR-NK細胞製剤の新規開発
2021 - 2024 安全で有効かつ、いつでも誰でも使えるCAR-NK細胞療法の新規開発
2018 - 2021 Development of NK Cell expansion by a novel membrane-bound chimeric cytokine
2016 - 2019 Development of Novel Immunotherapy of Cancer: NKp44-based Chimeric Antigen Receptors and Methods for Ex Vivo NK cell Expansion
2015 - 2018 Development of a novel chimeric antigen receptor T cell immunotherapy targeting immune checkpoint molecules

Show all

Papers (84)：

Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, Chansu Shin, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Minori Baba, Tomohiro Miyazaki, et al. NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma. Translational Oncology. 2022. 25. 101521-101521
Ko Kudo, Tsutomu Toki, Rika Kanezaki, Tatsuhiko Tanaka, Takuya Kamio, Tomohiko Sato, Shinya Sasaki, Masaru Imamura, Chihaya Imai, Kumiko Ando, et al. BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis. Haematologica. 2022. 107. 7. 1719-1725
Minori Baba, Masaru Imamura, Chihaya Imai. Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow. International journal of hematology. 2022. 115. 2. 151-152
Haruko Iwabuchi, Takayuki Takachi, Nobuhiro Kubo, Masaru Imamura, Hajime Umezu, Akihiko Saitoh, Chihaya Imai. Drug-induced panniculitis in a child with acute lymphoblastic leukemia. Pediatric blood & cancer. 2021. 69. 5. e29501
Yudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, Chansu Shin, Yasushi Kasahara, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Keichiro Mihara, et al. Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma. Translational oncology. 2021. 14. 12. 101227-101227

ｍore...

MISC (8)：

工藤耕, 土岐力, 金崎里香, 小林明恵, 佐藤知彦, 神尾卓哉, 佐々木伸也, 今村勝, 今井千速, 安藤久美子, et al. BRAFV600E-positive precursors as molecular markers of bone marrow disease in LCH(和訳中). 日本血液学会学術集会. 2021. 83回. OS2-2
笠原靖史, 久保暢大, 申将守, 高地貴行, 岩渕晴子, 今村勝, 今井千速. NKp44キメラ抗原受容体による新しいがん免疫治療の開発. 日本小児科学会雑誌. 2019. 123. 6. 1062-1062
Yasushi Kasahara, Changsu Shin, Takayuki Takachi, Nobuhiro Kubo, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai. Adoptive T Cell Immunotherapy Against a Wide Range of Malignancies by Using Chimeric Antigen Receptors with NK cell-like Specificity (NKp44-CAR). PEDIATRIC BLOOD & CANCER. 2017. 64. S22-S22
Yasushi Kasahara, Changsu Shin, Sakiko Yoshida, Takayuki Takachi, Nobuhiro Kubo, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai. A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer. BLOOD. 2016. 128. 22
Yasushi Kasahara, Changsu Shin, Takayuki Takachi, Haruko Iwabuchi, Masaru Imamura, Akihiko Saitoh, Chihaya Imai. Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity. BLOOD. 2015. 126. 23

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page